20111 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds Proteins, e.g. gelatin
FAST-DISSOLVING DOSAGE FORMS AND USES THEREOF
#2Protein Based Soft Chew Tablets
#3Sugar Free Soft Chew Tablets
#4NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE
#5PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#6PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#7USE OF RILUZOLE ORAL DISINTEGRATING TABLETS FOR TREATING DISEASES
#8FEED FOR ANADROMOUS FISH, METHOD FOR PRODUCING IT, METHOD OF INCREASING SEAWATER TOLERANCE, GROWTH AND FEED INTAKE OF ANADROMOUS FISH, FISH FEED FOR USE IN PREVENTING OR REDUCING SEVERITY OF CATARACTS
#9SOLID DISPERSIONS OF PSILOCYBIN
#10Dispenseable formulation for active pharmaceutical ingredients
#11PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#12SYMPATHETIC NERVE ACTIVATION AGENT AND SYMPATHETIC NERVE ACTIVATION COMPOSITION
#13OXYSTEROLS AND METHODS OF USE THEREOF
#14FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE
#15NOVEL LACTOBACILLUS PARACASEI ATG-E1 STRAIN OR COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
#16INCREASING PERMEATION FOR PRE-GASTRIC ABSORPTION OF ACTIVE PHARMACEUTICAL INGREDIENTS
#17STABILIZED APILIMOD COMPOSITIONS AND USES THEREOF
#18COMPRESSED TABLETS
#19STABILIZED APILIMOD COMPOSITIONS AND USES THEREOF
#20VETERINARY PHARMACEUTICAL COMPOSITIONS FOR DIRECT SYSTEMIC INTRODUCTION
#21FORMULATIONS OF PSILOCYBIN
#22PEPTIDE COMPOSITIONS FOR SLOWING DEGRADATION OF VITAMIN MINERAL SUPPLEMENTS, FOODS, PHARMACEUTICAL AND COSMETICS
#23COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS
#24PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
#25REDUCED FOAMING VACCINE COMPOSITIONS
#26COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS
#27METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS
#28CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER
#29PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#30CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
#31RILUZOLE PRODRUGS AND THEIR USE
#32STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE
#33ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING PROTEIN/POLYSACCHARIDE COACERVATES
#34Oxysterols and methods of use thereof
#35NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE
#36SEMI-SOLID FORMULATION FOR VOLUNTARY ORAL ADMINISTRATION OF BIOACTIVE COMPOUNDS TO RODENTS
#37Methods and products for treating subjects with autism spectrum disorders
#38PROCESS FOR PREPARING SOLID FORMULATIONS COMPRISING A HYDROPHOBIC COMPOUND DISPERSIBLE IN A COLD LIQUID AND RELATIVE SOLID FORMULATIONS
#39Riluzole prodrugs and their use
#40Prodrugs of riluzole and their method of use
#41COMPOSITION COMPRISING AT LEAST ONE TRITERPENE AND/OR AT LEAST ONE TRITERPENOID AND/OR AT LEAST ONE OF THE GLYCOSYLATED FORMS THEREOF
#42Device for cutting an animal treat composition
#43REDUCED FOAMING VACCINE COMPOSITIONS
#44USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES
#45RIMEGEPANT FOR CGRP RELATED DISORDERS
#46Method of preparing an animal treat composition
#47PRESSURIZED METERED DOSE INHALERS AND METHOD OF MANUFACTURE
#48Oral delivery systems based on in situ forming protein/polysaccharide coacervates
#49Immediate release abuse-deterrent granulated dosage forms
#50FORMULATIONS OF CYCLOSERINE COMPOUNDS AND APPLICATIONS THEREOF
#51Condensed-cyclic compound
#52Hydrogel tablet for relieving alcoholism and protecting the liver as well as preparation process and application thereof
#53Combination Therapy for Male Sexual Dysfunction
#54COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT
#55PRODUCING INGREDIENT DELIVERY DEVICES FOR RELEASE CONTROL
#56Pharmaceutical Compositions Including Low Dosages of Desmopressin
#57Ceritinib Formulation
#58Veterinary pharmaceutical compositions for direct systemic introduction
#59EFFERVESCENT POWDER DELIVERY SYSTEM
#60OXYSTEROLS AND METHODS OF USE THEREOF
#61Gel product instant-dissolving block and preparation method thereof
#62Peptide compositions for slowing degradation of vitamin mineral supplements, foods, pharmaceutical and cosmetics
#63Preparation containing benzimidazole derivative
#64Rimegepant for CGRP related disorders
#65Animal treat composition for delivery of oral medication
#66Process for Manufacturing Stable Epinephrine
#67Pharmaceutical compositions for direct systemic introduction
#68SUPPLEMENT TABLET AND PACKAGING
#69GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
#70REDUCED FOAMING VACCINE COMPOSITIONS
#71Immediate release abuse-deterrent granulated dosage forms
#72Compressed tablets
#73Fast dissolving tablet formulations and methods of making thereof
#74Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#75Compressed Tablets
#76Formulations of cycloserine compounds and applications thereof
#77Oral dosage form
#78Ceritinib formulation
#79TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#80ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS
#81Lyophilized pharmaceutical compositions for vaginal delivery
#82A CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
#83TIOPRONIN ORAL COMPOSITION
#84High-pH solid-state epinephrine formulation
#85Methods of making solid vaccine compositions having reduced foaming
#86Oxysterols and methods of use thereof
#87ORALLY DISINTEGRATING TABLETS FOR TREATMENT OF PEPTIC ULCER
#88DOPA Formulations for Treatments of Parkinson's Disease
#89Co-delivery of cholesterol lowering drugs and nutraceuticals
#90CERITINIB FORMULATION
#91Reduced foaming vaccine compositions
#92ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS
#93Pharmaceutical compositions for direct systemic introduction
#94FORMULATIONS FOR DELIVERING INSULIN
#95Fast dissolving tablet formulations and methods of making thereof
#96Delivery system comprising a core and a digestible polymer shell
#97COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT
#98Pharmaceutical formulations of desmopressin
#99Composition comprising tricalcium phosphate and gelatin for use in a method for the treatment of dyspepsia and related disorders
#100Compositions for treatment of dermatological diseases and conditions and methods of use thereof
#101Transoral dosage forms comprising sufentanil
#102Pressurized metered dose inhalers and method of manufacture
#103Immediate release abuse-deterrent granulated dosage forms
#104Production method for easy-to-take solid preparation (nucleated tablet), and easy-to-take solid preparation
#105Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
#106Soft lozenge compositions
#107Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof
#108Allergen dosage form
#109INHIBITING BLOOD PRESSURE DROP IN THE TREATMENT OF ERECTILE DYSFUNCTION
#110INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME
#111Oxysterols and methods of use thereof
#112Delivery system comprising a core and a digestible polymer shell
#113ORAL DOSAGE FORM COMPRISING TRI-SUBSTITUTED GLYCEROL COMPOUNDS
#114Pharmaceutical formulations of desmopressin
#115TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#116ORALLY DISINTEGRATING TABLET CONTAINING SOLID LIPID PARTICLES AND METHODS FOR THEIR PREPARATION AND USE
#117ORALLY DISPERSIBLE TABLET
#118Pressurised metered dose inhalers and method of manufacture
#119Compositions for use in treatment of hyperpigmentation and methods of use thereof
#120Organic Compounds
#121Ingestible formulations for transient, noninvasive reduction of gastric volume
#122Allergen dosage form
#123Reduced foaming vaccine compositions
#124Pharmaceutical formulations of desmopressin
#125Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#126Composition for Intraocular Implantation of Bevacizumab
#127Compositions and methods for increasing iron intake in a mammal
#128Oral transmucosal pharmaceutical compositions including testosterone and an aromatase inhibitor
#129Stable montelukast solution
#130Decontaminant edible product, methods of production and uses thereof
#131FORMULATIONS FOR DELIVERING INSULIN
#132Methods using desmopressin acetate in orodispersible form
#133Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
#134Pharmaceutical compositions for direct systemic introduction
#135Immediate release abuse-deterrent granulated dosage forms
#136Immediate release abuse-deterrent granulated dosage forms
#137Immediate Release Abuse-Deterrent Granulated Dosage Forms
#138Methods for treating polycystic kidney disease
#139METHODS AND DELIVERY SYSTEM FOR BENEFICIAL ADDITIVE AND SUBTRACTIVE BIOLOGICAL AGENTS TO PROMOTE BALANCED MAMMALIAN GASTROINTESTINAL FLORA
#140Polymer conjugated protein micelles
#141Allergen dosage form
#142Methods for treating diseases using isoindoline compounds
#143Mucosal bioadhesive slow release carrier for delivering active principles
#144Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#145Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
#146Compositions for use in treatment of dermatological diseases and conditions
#147Methods and formulations for treating sialic acid deficiencies
#148Methods and formulations for treating sialic acid deficiencies
#149Orally bioavailable lipid-based constructs
#150Sustained drug release and improved product stability using non-covalent particle coating methods
#151Orally dispersible tablet
#152Orally dispersible tablet
#153Mucosal bioadhesive slow release carrier for delivering active principles
#154MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES
#155Pharmaceutical Compositions Including Low Dosages of Desmopressin
#156ORGANIC COMPOUNDS
#157ORALLY DISPERSIBLE TABLET
#158Coumarin compounds as melanogenesis modifiers and uses thereof
#159Freeze-dried fibrin matrices and methods for preparation thereof
#160Process for producing instantaneous cold soluble gelatin and product thereof
#161Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#162Methods of treatment using orodispersible desmopressin pharmaceutical formulations
#163Therapeutic agent for spinal cord injuries
#164Oxazole pyridine derivatives useful as S1P1 receptor agonists
#165TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS
#166Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
#167Surface active proteins as excipients in solid pharmaceutical formulations
#168CHEWABLE GELLED EMULSIONS
#169NOVEL GASTRORETENTIVE DELIVERY SYSTEM
#170Decontaminant edible product, methods of production and uses thereof
#171Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
#172Protein Hydrolysate Excipients
#173Continuous Fiber Layer Comprising an Active Substance on the Basis of Bio-Polymers, the use Thereof, and Method for the Production Thereof
#174Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds
#175Treatment and prevention of tuberculosis
#176Modified protein excipient for delayed-release tablet
#177Prolonged release bioadhesive therapeutic systems
#178OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
#179Method of imparting heat resistance to lactoferrin
#180DECONTAMINANT EDIBLE PRODUCT, METHODS OF PRODUCTION AND USES THEREOF
#181Mucosal bioadhesive slow release carrier for delivering active principles
#182Methods and compositions for treating dermatological diseases and conditions
#183Freeze-dried fibrin matrices and methods for preparation thereof
#184Formulations for delivering insulin
#185ELASTIN-LIKE POLYMER DELIVERY VEHICLES
#186MUCOSAL BIOADHESIVE SLOW RELEASE CARRIER FOR DELIVERING ACTIVE PRINCIPLES
#187THERAPEUTIC AGENT FOR SPINAL CORD INJURIES
#188Orally Bioavailable Lipid-Based Constructs
#189Chewable sustained release formulations
#190Pharmaceutical Compositions Including Low Dosages of Desmopressin
#191ORGANIC COMPOUNDS
#192Steroidal compounds as melanogenesis modifiers and uses thereof
#193TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE
#194Pharmaceutical formulations
#195OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
#196THIOZOLIDINEDIONE DERIVATIVES AS PI3 KINASE INHIBITORS
#197Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles
#198Treatment of oropharyngeal candidiasis in cancer patients
#199Compositions and Methods for Enhancement of Sexual Function
#200Mucoadhesive Tetracycline Formulations
#201PHARMACEUTICAL COMPOSITION WHICH REDUCES OR ELIMINATES DRUG ABUSE POTENTIAL
#202Pharmaceutical compositions including low dosages of desmopressin
#203COMPOSITION COMPRISING COENZYME Q10
#204Pharmaceutical compositions including low dosages of desmopressin
#205Decontaminant edible product, methods of production and uses thereof
#206Ingestible formulations for transient, noninvasive reduction of gastric volume
#207GEL DELIVERY SYSTEM FOR ORAL ADMINISTRATION OF MEDICAMENTS
#208Allergen dosage form
#209Allergen dosage form
#210RAPIDLY DISINTEGRATING LYOPHILIZED ORAL FORMULATIONS OF A THROMBIN RECEPTOR ANTAGONIST
#211Compositions and methods for treating conditions of the nail unit
#212Keratin-Based Powders and Hydrogel for Pharmaceutical Applications
#213Quercetin-containing composition, methods of making, and methods of using
#214Botulinum toxin formulation for oral administration
#215Pharmaceutical compositions including low dosages of desmopressin
#216Method for administering medicaments to subjects with swallowing difficulties and disorders
#217Protein hydrolysate excipients
#218Preparation for gastric buoyant sustained drug release dosage form
#219Prolonged release bioadhesive therapeutic systems
#220Pharmaceutical composition which reduces or eliminates drug abuse potential
#221Delivery system for biological component
#222Composition for the treatment of arthrosis/arthritis, especially for treating joints
#223Flexible Solid Dosage Forms and Methods of Making and Using the Same
#224Use of a polypeptide for treatment of pruritus in animals
#225Freeze-dried fibrin matrices and methods for preparation thereof
#226Compositions and methods for treating conditions of the nail unit
#227Controlled release arginine alpha-ketoglutarate
#228Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same
#229Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
#230Orodispersible dosage forms of desmopressin acetate
#231Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
#232Prolonged release bioadhesive therapeutic systems
#233Delivery system for biological component
#234Biocompatible protein particles, particle devices and methods thereof
#235Dosage forms of tafamidis and its pharmaceutically acceptable salt thereof
#236Fast-dispersing dosage forms containing fish gelatin